Kevin Fitzpatrick Named Chief Innovation Officer of the American College Of Cardiology

WASHINGTON, Jan. 26, 2015 /PRNewswire-USNewswire/ -- Kevin Fitzpatrick has been named Executive Vice President and Chief Innovation Officer of the American College of Cardiology, a move that signals the college's commitment to seeking new and innovative ways to support members and improve heart health.

American College of Cardiology names Kevin Fitzpatrick Chief Innovation Officer.
"This new position will help the ACC continue its role as a leader in cardiology and among medical societies by exploring new ways to improve cardiovascular care and new ways to address the challenges in medicine," said ACC Chief Executive Officer Shal Jacobovitz. "The ACC has been a leader in establishing the National Cardiovascular Data Registry, which provides a network for collecting and accessing clinical data that supports the delivery of quality medical care and the development of important new research. Kevin is forward thinking and the right leader to help the ACC continue its growth and innovation."

The establishment of the chief innovation officer represents an investment in the continuation, and acceleration, of the ACC's growth. Fitzpatrick's duties will include leading the ACC's team of Innovation Ambassadors in partnering with 1776, a global incubator and investment fund, to identify healthcare startups solving the biggest challenges facing health care today.

"I am proud and humbled to be asked to assume this role and to lead this new initiative at the ACC," Fitzpatrick said. "I look forward to accelerating our engagement with innovators across the healthcare landscape and helping to expand upon the remarkable success of the College."

As the ACC continues to meet the evolving needs of cardiovascular professionals and their patients, innovation will be a necessity. The ACC is committed to fulfilling its mission to provide the best possible care to patients while supporting efforts to improve heart health around the world.

The American College of Cardiology is a 47,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit

Photo -

To view the original version on PR Newswire, visit:

SOURCE American College of Cardiology

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.